Mary Smith
Lead Designer at
Company Name
Mary Smith
Lead Designer at
Company Name
Mary Smith
Lead Designer at
Company Name
Mary Smith
Lead Designer at
Company Name
Several studies have been conducted to evaluate the effectiveness of the HOLOROAD system in individuals with central vision loss caused by conditions such as age-related macular degeneration, diabetic maculopathy, and other ophthalmic diseases.
The studies included participants aged from 16 to 88 years old, who used the device during their daily activities.
The results showed significant improvements:
Visual acuity while using HOLOROAD glasses improved.
Reading speed increased substantially after regular use.
80% of participants expressed their willingness to continue using the device after the evaluation.
HOLOROAD has proven to be an effective assistive technology, enhancing visual functions and supporting independent living for people with low vision.
HOLOROAD established a new partnership with Beter Zien Revoir with its headquarters in The
Hague the company specialises in providing a broad spectrum services for visually impaired
patients in Nederland and Germany. Having 80 store locations and database of 1 million
customers with visually impairment Beter Zien Revoir is one of the biggest in the region.